Yahoo · Sep 11, 2026
Xylem Stock: Is XYL Underperforming the Industrial Sector?
Xylem has underperformed the Industrial sector over the past year, but analysts are cautiously optimistic about the stock’s prospects.
NYSE · XYL
Xylem Inc.
Industrials · Industrial - Machinery
$107.50
Up+$0.01 (+0.01%)
Updated Sep 16, 2026, 11:53 AM
SID Score
5.3/10
Composite research score
Smart Money
62/100
Neutral
- Market cap
- 34.08B
- P/E ratio
- 35.95
- Dividend yield
- 1.49%
- 52-week range
- $105.29 – $146.55
- Volume
- 2.39M
- Avg. volume
- 1.32M
Price performance
XYL price history
1M range · 20 trading sessions · Daily adjusted prices
XYL closed at $107.50 after 20 trading sessions, down 5.65% for the selected period.
- Last close
- $107.50
- Period change
- -5.65%
- Period low
- $105.69
- Period high
- $116.21
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $106.99 | $108.24 | $106.165 | $107.50 | 2.39M |
| Sep 14, 2026 | $106.23 | $108.74 | $106.00 | $107.49 | 2.97M |
| Sep 11, 2026 | $108.54 | $108.92 | $106.25 | $106.96 | 1.85M |
| Sep 10, 2026 | $106.63 | $107.4716 | $105.70 | $106.55 | 3.39M |
| Sep 9, 2026 | $108.09 | $109.04 | $106.6901 | $107.64 | 6.87M |
| Sep 8, 2026 | $106.50 | $110.13 | $106.0347 | $108.81 | 3.61M |
| Sep 4, 2026 | $107.53 | $109.1375 | $105.475 | $105.69 | 2.43M |
| Sep 3, 2026 | $107.82 | $108.35 | $106.41 | $107.89 | 1.64M |
| Sep 2, 2026 | $107.265 | $107.61 | $105.72 | $106.74 | 1.98M |
| Sep 1, 2026 | $109.68 | $110.20 | $106.59 | $106.89 | 1.88M |
| Aug 31, 2026 | $110.42 | $111.29 | $110.00 | $110.11 | 2.01M |
| Aug 28, 2026 | $112.88 | $113.71 | $110.455 | $111.31 | 1.46M |
| Aug 27, 2026 | $112.55 | $113.32 | $110.84 | $112.65 | 2.11M |
| Aug 26, 2026 | $113.13 | $114.64 | $113.00 | $113.42 | 1.45M |
| Aug 25, 2026 | $115.15 | $115.68 | $112.265 | $112.81 | 2.23M |
| Aug 24, 2026 | $114.56 | $115.43 | $113.46 | $114.18 | 1.6M |
| Aug 21, 2026 | $114.28 | $114.73 | $112.94 | $113.42 | 1.46M |
| Aug 20, 2026 | $115.61 | $116.1999 | $113.00 | $113.44 | 1.51M |
| Aug 19, 2026 | $113.99 | $116.815 | $113.98 | $116.21 | 1.58M |
| Aug 18, 2026 | $116.00 | $116.05 | $112.50 | $113.94 | 2.35M |
Latest XYL news
The latest Smart Investors Daily articles mentioning XYL.
Stock researchCompany · Overview
XYL research
Overview
Company profile and research snapshot.
Company profile
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $171.71
- Implied upside
- —
- Analysts
- 27
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 24, 2026 | Jefferies | Buy | — |
| Aug 13, 2026 | UBS | Neutral | — |
| Jul 30, 2026 | UBS | Neutral | — |
| Jul 29, 2026 | RBC Capital | Outperform | — |
| Jul 29, 2026 | Barclays | Overweight | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 27, 2026
Xylem (XYL) Down 7.1% Since Last Earnings Report: Can It Rebound?
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo · Aug 26, 2026
GE HealthCare Technologies (GEHC) Names A New CFO As Its Undervalued Narrative Faces A Test
GE HealthCare Technologies (GEHC) has drawn fresh attention after announcing William K. Grogan as its incoming Chief Financial Officer, effective September 14, 2026, following his finance leadership roles at Xylem and IDEX. For investors watching GE HealthCare Technologies, the recent CFO news comes after a strong 30 day share price return of 22% and a 90 day share price return of 15.7%. However, the year to date share price return is down 10.76%, and the 1 year total shareholder return is...
Yahoo · Aug 20, 2026
Xylem (XYL) Could Be 23% Below Fair Value Following Its Q2 Profit Outlook Lift
Xylem (XYL) is back in focus after its Q2 FY2026 results showed stronger profitability. The company raised adjusted EPS guidance and improved its adjusted EBITDA margin outlook, despite trimming its full year revenue forecast. See our latest analysis for Xylem. Xylem's latest earnings update has arrived after a mixed share price run, with the stock at US$116.21 and a year to date share price return down 15.24%, while the 3 year total shareholder return of 19.86% contrasts with a 1 year total...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
